Showing results (351-360 of 566) with videos related to
Sort By:
Pageof 57
The Journal of Rheumatology|September 3, 2011
OMERACT 10 Sharp Symposium: important findings in examination of imaging methods for measurement of joint damage in rheumatoid arthritisVibeke Strand, Sarah R Kingsbury, Thasia Woodworth, et al.RMD Open|June 2, 2022
Effect of tofacitinib on pain, fatigue, health-related quality of life and work productivity in patients with active ankylosing spondylitis: results from a phase III, randomised, double-blind, placebo-controlled trialVictoria Navarro-Compán, James Cheng-Chung Wei, Filip Van den Bosch, et al.The Journal of Rheumatology|October 13, 2009
Fibromyalgia syndrome module at OMERACT 9: domain constructPhilip Mease, Lesley M Arnold, Ernest H Choy, et al.Rheumatology International|August 8, 2025
The advocacy effect: a grounded theory study on the inclusion of caregivers or nearest support persons in research to better understand patient outcomes in rheumatoid arthritisJosé B Negrón, Maria A Lopez-Olivo, Loreto Carmona, et al.The Journal of Rheumatology|July 3, 2015
Is Chronic Pain a Disease in Its Own Right? Discussions from a Pre-OMERACT 2014 Workshop on Chronic PainAnn M Taylor, Kristine Phillips, Justin O Taylor, et al.Drug Safety|June 11, 2016
Pregnancy Outcomes in the Tofacitinib Safety Databases for Rheumatoid Arthritis and PsoriasisMegan E B Clowse, Steven R Feldman, John D Isaacs, et al.Arthritis Research & Therapy|July 29, 2024
Upadacitinib monotherapy versus methotrexate monotherapy in patients with rheumatoid arthritis: efficacy and safety through 5 years in the SELECT-EARLY randomized controlled trialRonald van Vollenhoven, Vibeke Strand, Tsutomu Takeuchi, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 10, 2003
Characterization and analysis of the proximal Janus kinase 3 promoterMartin Aringer, Sigrun R Hofmann, David M Frucht, et al.Zeitschrift Fur Rheumatologie|May 16, 2019
[Survey of rheumatologists in Saxony, Saxony-Anhalt and Thuringia regarding the occupational situation and activities in further education: no way out of the undersupply of rheumatological care]Gernot Keyßer, Christoph G O Baerwald, Maren Sieburg, et al.Arthritis & Rheumatology (Hoboken, N.J.)|November 3, 2020
Effect of Nintedanib on Lung Function in Patients With Systemic Sclerosis-Associated Interstitial Lung Disease: Further Analyses of a Randomized, Double-Blind, Placebo-Controlled TrialToby M Maher, Maureen D Mayes, Michael Kreuter, et al.Pageof 57